Celltrion to sell portfolio of Takeda drugs to CBC Group

Celltrion to sell portfolio of Takeda drugs to CBC Group

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

Celltrion puts Takeda’s assets up for sale after 3 years

Celltrion puts Takeda’s assets up for sale after 3 years

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

S.Korea, Japan compete in gastroesophageal reflux drug market

S.Korea, Japan compete in gastroesophageal reflux drug market

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

Celltrion finalizes $278mn acquisition of Takeda's primary care assets

Celltrion finalizes $278mn acquisition of Takeda's primary care assets

South Korea's biopharmaceutical firm Celltrion Inc. has completed the $278 million acquisition of Takeda Pharmaceutical Company Ltd's primary care a...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner